Evidence map›Paper›PMID 35348133›Full record

ArticleNanoscale2022

Magneto-optical hyperthermia agents based on probiotic bacteria loaded with magnetic and gold nanoparticles.

Víctor Garcés, Ana González, Natividad Gálvez, José M Delgado-López, Jose J Calvino, Susana Trasobares, Yilian Fernández-Afonso, Lucía Gutiérrez, José M Dominguez-Vera

Open access · hybridAbstract read
In one paragraph

Article in Nanoscale, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Probiotic-Based Materials as Living Therapeutics.Advanced materials (Deerfield Beach, Fla.) · 2026
    Review
  4. Review
  5. Review
  6. Microbiota and gastric cancer: from molecular mechanisms to therapeutic strategies.Frontiers in cellular and infection microbiology · 2025
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Víctor GarcésDepartamento de Química Inorgánica and Instituto de Biotecnología, Universidad de Granada, 18071 Granada, Spain. josema@ugr.es.ORCID http://orcid.org/0000-0003-2441-7436
Ana GonzálezDepartamento de Química Inorgánica and Instituto de Biotecnología, Universidad de Granada, 18071 Granada, Spain. josema@ugr.es.ORCID http://orcid.org/0000-0001-9463-5717
Natividad GálvezDepartamento de Química Inorgánica and Instituto de Biotecnología, Universidad de Granada, 18071 Granada, Spain. josema@ugr.es.
José M Delgado-LópezDepartamento de Química Inorgánica and Instituto de Biotecnología, Universidad de Granada, 18071 Granada, Spain. josema@ugr.es.ORCID http://orcid.org/0000-0001-9643-9322
Jose J CalvinoDepartamento Ciencia de Materiales e Ingeniería Metalúrgica y Química Inorgánica, Universidad de Cádiz, 11510 Cádiz, Spain.ORCID http://orcid.org/0000-0002-0989-1335
Susana TrasobaresDepartamento Ciencia de Materiales e Ingeniería Metalúrgica y Química Inorgánica, Universidad de Cádiz, 11510 Cádiz, Spain.ORCID http://orcid.org/0000-0003-3820-4327
Yilian Fernández-AfonsoDepartamento de Química Analítica, Instituto de Nanociencia y Materiales de Aragón (INMA), CSIC - Universidad de Zaragoza and CIBER-BBN, 50018 Zaragoza, Spain. lu@unizar.es.
Lucía GutiérrezDepartamento de Química Analítica, Instituto de Nanociencia y Materiales de Aragón (INMA), CSIC - Universidad de Zaragoza and CIBER-BBN, 50018 Zaragoza, Spain. lu@unizar.es.ORCID http://orcid.org/0000-0003-2366-3598
José M Dominguez-VeraDepartamento de Química Inorgánica and Instituto de Biotecnología, Universidad de Granada, 18071 Granada, Spain. josema@ugr.es.ORCID http://orcid.org/0000-0002-1639-744X
Universidad de Granada · ESUniversidad de Cádiz · ESUniversidad de Zaragoza · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Probiotic bacteria were used as carriers of metallic nanoparticles to develop innovative oral agents for hyperthermia cancer therapy. Two synthetic strategies were used to produce the different therapeutic agents. First, the probiotic bacterium

Indexed as

Hyperthermia, InducedMetal NanoparticlesProbioticsBacteriaGoldHumansHyperthermiaMagnetic FieldsGold

Identifiers

PMID35348133
PMCPMC9008706
OpenAlexW4221120029

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.